Seoul, South Korea

Doo-Sik Kim


 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Seoul KR (2003)
  • Seodaemun-Gu, KR (2015)
  • Seoul, KR (1998 - 2020)

Company Filing History:


Years Active: 1998-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Doo-Sik Kim

Introduction

Doo-Sik Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the treatment of vascular-related diseases. With a total of 9 patents to his name, Kim's work has the potential to impact many lives.

Latest Patents

Among his latest patents is a method for treating vascular-related diseases. This method involves administering a peptide with a specific sequence, which may help in conditions such as edema and ischemia. Another notable patent is a monoclonal antibody against human D-dimer, which can be used as a diagnostic agent for screening and detecting D-dimer in vivo. This antibody specifically reacts with D-dimer and cross-linked fibrin, making it a valuable tool in medical diagnostics.

Career Highlights

Doo-Sik Kim has worked with various companies, including Eyegene Inc. His innovative approaches and research have positioned him as a key figure in his field. His patents reflect a deep understanding of medical challenges and a commitment to finding effective solutions.

Collaborations

Throughout his career, Kim has collaborated with notable colleagues such as Kwang-Hoe Chung and Hyun-Ju Doh. These partnerships have likely contributed to the success of his inventions and the advancement of medical technology.

Conclusion

Doo-Sik Kim's contributions to medical innovation are noteworthy. His patents and collaborative efforts demonstrate his dedication to improving healthcare through technology. His work continues to pave the way for advancements in the treatment of vascular-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…